Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of erlotinib plus fixed dose rate gemcitabine in advanced pancreatic cancer
2006-001238-41Phase 2Completed
- Sponsor
- AOU Policlinico di Modena
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of erlotinib and gemcitabine in pancreatic adenocarcinoma (PDAC), sponsored by AOU Policlinico di Modena. Started Jul 2007; status: completed.
02
Drugs
erlotinibgemcitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2006-001238-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001238-41.